1832 Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,059
| Closed | -$2.12M | – | 712 |
|
|
2025
Q1 | $2.12M | Sell |
5,059
-83,823
| -94% | -$36.4M | ﹤0.01% | 469 |
|
|
2024
Q4 | $36.7M | Buy |
88,882
+84,487
| +1,922% | +$37.1M | 0.03% | 219 |
|
|
2024
Q3 | $2.22M | Sell |
4,395
-124,096
| -97% | -$60.3M | ﹤0.01% | 508 |
|
|
2024
Q2 | $62.6M | Buy |
128,491
+125,498
| +4,193% | +$63M | 0.05% | 172 |
|
|
2024
Q1 | $1.62M | Sell |
2,993
-2,001
| -40% | -$1.09M | ﹤0.01% | 537 |
|
|
2023
Q4 | $2.77M | Sell |
4,994
-8,687
| -63% | -$4.08M | ﹤0.01% | 436 |
|
|
2023
Q3 | $5.98M | Sell |
13,681
-802
| -6% | -$400K | 0.01% | 373 |
|
|
2023
Q2 | $7.27M | Buy |
14,483
+7,647
| +112% | +$3.66M | 0.01% | 364 |
|
|
2023
Q1 | $3.42M | Buy |
6,836
+240
| +4% | +$115K | 0.01% | 447 |
|
|
2022
Q4 | $2.69M | Sell |
6,596
-883
| -12% | -$343K | ﹤0.01% | 482 |
|
|
2022
Q3 | $2.44M | Buy |
7,479
+317
| +4% | +$116K | ﹤0.01% | 487 |
|
|
2022
Q2 | $2.51M | Buy |
7,162
+1,917
| +37% | +$782K | ﹤0.01% | 486 |
|
|
2022
Q1 | $2.83M | Buy |
+5,245
| New | +$2.76M | ﹤0.01% | 494 |
|
|
2021
Q4 | – | Sell |
-590
| Closed | -$374K | – | 790 |
|
|
2021
Q3 | $374K | Buy |
+590
| New | +$396K | ﹤0.01% | 580 |
|
|
2020
Q1 | – | Sell |
-4
| Closed | -$1K | – | 715 |
|
|
2019
Q4 | $1K | Sell |
4
-1,996
| -100% | -$526K | ﹤0.01% | 662 |
|
|
2019
Q3 | $545K | Buy |
+2,000
| New | +$557K | ﹤0.01% | 459 |
|
|
2019
Q2 | – | Sell |
-160
| Closed | -$36K | – | 720 |
|
|
2019
Q1 | $36K | Hold |
160
| – | – | ﹤0.01% | 519 |
|
|
2018
Q4 | $30K | Sell |
160
-15,036
| -99% | -$3.08M | ﹤0.01% | 509 |
|
|
2018
Q3 | $3.67M | Buy |
15,196
+15,036
| +9,398% | +$3.65M | 0.01% | 314 |
|
|
2018
Q2 | $38K | Hold |
160
| – | – | ﹤0.01% | 524 |
|
|
2018
Q1 | $31K | Hold |
160
| – | – | ﹤0.01% | 554 |
|
|
2017
Q4 | $25K | Hold |
160
| – | – | ﹤0.01% | 578 |
|
|
2017
Q3 | $25K | Hold |
160
| – | – | ﹤0.01% | 596 |
|
|
2017
Q2 | $26K | Hold |
160
| – | – | ﹤0.01% | 575 |
|
|
2017
Q1 | $25K | Hold |
160
| – | – | ﹤0.01% | 622 |
|
|
2016
Q4 | $19K | Hold |
160
| – | – | ﹤0.01% | 606 |
|
|
2016
Q3 | $18K | Hold |
160
| – | – | ﹤0.01% | 575 |
|
|
2016
Q2 | $15K | Hold |
160
| – | – | ﹤0.01% | 591 |
|
|
2016
Q1 | $13K | Hold |
160
| – | – | ﹤0.01% | 547 |
|
|
2015
Q4 | $12K | Hold |
160
| – | – | ﹤0.01% | 572 |
|
|
2015
Q3 | $12K | Hold |
160
| – | – | ﹤0.01% | 557 |
|
|
2015
Q2 | $10K | Hold |
160
| – | – | ﹤0.01% | 591 |
|
|
2015
Q1 | $12K | Sell |
160
-400
| -71% | -$31.1K | ﹤0.01% | 545 |
|
|
2014
Q4 | $42K | Hold |
560
| – | – | ﹤0.01% | 513 |
|
|
2014
Q3 | $33K | Hold |
560
| – | – | ﹤0.01% | 528 |
|
|
2014
Q2 | $37K | Hold |
560
| – | – | ﹤0.01% | 519 |
|
|
2014
Q1 | $34K | Buy |
+560
| New | +$33.4K | ﹤0.01% | 524 |
|
Other funds holding IDXX
1832 Asset Management's IDXX Position: Q2 2025 in Review
1832 Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 5,059 shares — an estimated $2.12M sold.
1832 Asset Management first reported a position in IDXX in Q1 2014 and held it in 37 quarters. The position peaked at $62.6M in Q2 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.
- 1832 Asset Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
- 1832 Asset Management sold 5,059 Idexx Laboratories shares in Q2 2025, an estimated $2.12M.
- 1832 Asset Management first reported a position in Idexx Laboratories in Q1 2014 and held it in 37 quarters.
- 1832 Asset Management's Idexx Laboratories position peaked at $62.6M in Q2 2024.
- 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.
Based on 1832 Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.